Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Amgn crawled date : 2022 - 06 - 10 save search
AMGEN ANNOUNCES WEBCAST OF GOLDMAN SACHS 43RD ANNUAL HEALTHCARE CONFERENCE
Published: 2022-06-10 (Crawled : 21:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
conference
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -4.41%
H: 3.01%
C: 0.79%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.85%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -5.18%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: 0.0%
antibody results
Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -4.41%
H: 3.01%
C: 0.79%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.85%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -5.18%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: 0.0%